Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mark Lebwohl, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT01525875
First received: February 1, 2012
Last updated: January 19, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)